Phase II-Study With Nelarabine in Patients With Refractory Or Relapsed T- ALL or T-Lymphoblastic Lymphoma (Amend.7)
Phase of Trial: Phase II
Latest Information Update: 08 Mar 2018
At a glance
- Drugs Nelarabine (Primary)
- Indications Non-Hodgkin's lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
- 20 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jun 2008 New trial record.